turps the info' I read appears to be a poster at a pain conference however I would imagine the coy would be busy working on an oxymorphone paper where the reviewers would believe the results could be replicated . If this comes to pass the oxym' patch could indeed be an attractive proposition to potential partners . The esoterics of technical development !!